Company intelligence / Profile preview

King River Capital

Surry Hills, New South Wales, Australia

Ownership: Private
Development stage: Other

Overview

King River Capital is an active venture capital firm established in 2018 that primarily invests in high-growth technology businesses, especially in North America and Australia. While it invests across multiple sectors—including companies with healthcare and AI health applications—King River itself is not a biotech, pharma, or healthcare company and does not have clinical or therapeutic programs.

Industry: Investors

Beyond the preview

Go deeper on King River Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on King River Capital.

Explore the full profile